Company:  SYROS PHARMACEUTICALS, IN ... (SYRS)
Form Type:  4
Filing Date:  6/10/2021 
CIK:  0001556263 
Address:  35 CAMBRIDGE PARK DRIVE 
City, State, Zip:  CAMBRIDGE, Massachusetts 02140 
Telephone:  617-744-1340 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.74  
Change: 
-0.24 (-4.82%)  
Trade Time: 
Sep 21  
Market Cap: 
$293.55M
Trade SYRS now with 

© 2021  
Description of Business
We are a biopharmaceutical company seeking to redefine the power of small molecules to control the expression of genes. Based on our unique ability to elucidate regulatory regions of the genome, we aim to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches. We are currently focused on developing treatments for cancer and diseases resulting from mutations of a single gene, also known as monogenic diseases, and building a clinical stage pipeline of gene control medicines.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES